Terry, Thank you for your comments. Indeed screeners are very well suited to tracking changes in pilot studies. They allow one to monitor change in a typical treatment setting which can bode well for gaining high quality research results (as opposed to clinical trials that may be blinded &/randomized). And when it is possible to use more broad-ranging tools such as symptom logs and the MYMOP, one can approach a patient’s overall well-being and sense of their progress as well. Insurance reimbursement is typically ‘evidence-based’ and screeners may be a helpful tool in working towards greater reimbursement of alternatives in mental health care.